Michele Torella

Michele Torella

Auto-generated profile, based on publicly available information

Michele Torella

Department of Cardio-Thoracic and Respiratory Sciences, Second University of Naples, Naples, Italy

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in JACC
Verified
Journal Article
Closed access
GEGeorgina M Ellison-Hughes
Georgina M Ellison-Hughes
DTDaniele Torella
Daniele Torella
SDSanto Dellegrottaglie
Santo Dellegrottaglie
CPClaudia C. Pérez-Martínez
Claudia C. Pérez-Martínez
APArmando Perez De Prado
Armando Perez De Prado
BNBernardo Nadal-Ginard
Bernardo Nadal-Ginard

1 July 2010 in American Heart Journal
Verified
Journal Article
Closed access
MTMichele Torella
Michele Torella
DTDaniele Torella
Daniele Torella
PCPaolo Chiodini
Paolo Chiodini
MFMarco Franciulli
Marco Franciulli
GRGiampaolo Romano
Giampaolo Romano
GNGianantonio Nappi
Gianantonio Nappi

24 March 2014 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
DTDaniele Torella
Daniele Torella
GEGeorgina M Ellison-Hughes
Georgina M Ellison-Hughes
MTMichele Torella
Michele Torella
CVCarla Vicinanza
Carla Vicinanza
IAIolanda Aquila
Iolanda Aquila
FSFerdinando Carlo Sasso
Ferdinando Carlo Sasso
Background: Diabetes mellitus ( DM ) has multifactorial detrimental effects on myocardial tissue. Recently, carbonic anhydrases ( CAs ) have been shown to play a major role in diabetic microangiopathy but their role in the diabetic cardiomyopathy is still unknown. Methods and Results: We obtained left ventricular samples from patients with DM type 2 (DM‐T2) and nondiabetic ( NDM ) patients with postinfarct heart failure who were undergoing surgical coronary revascularization. Myocardial levels of CA ‐I and CA‐ II were 6‐ and 11‐fold higher, respectively, in DM ‐T2 versus NDM patients. Elevated CA ‐I expression was mainly localized in the cardiac interstitium and endothelial cells. CA ‐I induced by high glucose levels hampers endothelial cell permeability and determines endothelial cell apoptosis in vitro. Accordingly, capillary density was significantly lower in the DM ‐T2 myocardial samples (mean± SE =2152±146 versus 4545±211/mm 2 ). On the other hand, CA‐II was mainly upregulated in cardiomyocytes. The latter was associated with sodium‐hydrogen exchanger‐1 hyperphosphorylation, exaggerated myocyte hypertrophy (cross‐sectional area 565±34 versus 412±27 μm 2 ), and apoptotic death (830±54 versus 470±34 per 10 6 myocytes) in DM ‐T2 versus NDM patients. CA‐II is activated by high glucose levels and directly induces cardiomyocyte hypertrophy and death in vitro, which are prevented by sodium‐hydrogen exchanger‐1 inhibition. CA‐II was shown to be a direct target for repression by micro RNA ‐23b, which was downregulated in myocardial samples from DM ‐T2 patients. MicroRNA‐23b is regulated by p38 mitogen‐activated protein kinase, and it modulates high‐glucose CA‐II–dependent effects on cardiomyocyte survival in vitro. Conclusions: Myocardial CA activation is significantly elevated in human diabetic ischemic cardiomyopathy. These data may open new avenues for targeted treatment of diabetic heart failure.

21 April 2004 in JAMA
Verified
Journal Article
Closed access
PDF file
FSFerdinando Carlo Sasso
Ferdinando Carlo Sasso
OCOrnella Carbonara
Ornella Carbonara
RNRodolfo Nasti
Rodolfo Nasti
BCBiagio Campana
Biagio Campana
RMRaffaele Marfella
Raffaele Marfella
DCDomenico Cozzolino
Domenico Cozzolino
Research from JAMA — Glucose Metabolism and Coronary Heart Disease in Patients With Normal Glucose Tolerance — ContextSeveral investigations as well as prospective studies have shown a significant correlation between glucose metabolism and atherosclerosis in patients without diabetes, but differences in parameters of glucose metabolism among the various degrees of coronary disease in such patients have not been specifically evaluated.ObjectiveTo investigate glucose metabolism in patients with normal glucose tolerance (NGT) and coronary heart disease (CHD).Design, Setting, and ParticipantsCross-sectional study of 234 men (mean [SD] age, 56.2 [6.1] years) with NGT and suspected CHD who were admitted from January 1 through June 30, 2001, to an academic medical center in Italy for coronary angiography.Main Outcome MeasuresCorrelation of glucose metabolic factors and extent of atherosclerosis determined by coronary angiography. Factors included levels of fasting and postload glucose and insulin, glycosylated hemoglobin (HbA1c), and lipids, as well as insulin resistance measured by homeostasis model assessment (HOMA-IR).ResultsPatients were divided into 4 groups based on coronary angiography: no significant stenosis (n = 42), 1-vessel disease (n = 72), 2-vessel disease (n = 64), and 3-vessel disease (n = 56). Simple correlation analysis showed that the factors correlated with the extent of atherosclerosis were levels of postload glucose (r = 0.667), HbA1c (r = 0.561), postload insulin (r = 0.221), and fasting insulin (r = 0.297), as well as HOMA-IR (r = 0.278) (P<.001 for all). Multiple stepwise regression analysis suggested that the factors independently associated with the number of stenosed coronary arteries were levels of postload plasma glucose (r = 0.572), HbA1c (r = 0.413), postload insulin (r = 0.267), and fasting insulin (r = 0.174), as well as HOMA-IR (r = 0.250) (P<.001 for all). Similar results were obtained after grouping patients by Duke Myocardial Jeopardy Score.ConclusionsFor patients with NGT and different extents of atherosclerotic disease, postload glycemia and HbA1c level are not equally distributed but are significantly higher in those with more severe disease. This suggests that the glycemic milieu correlates with the cardiovascular risk according to a linear model.

10 February 2013 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
Ignazio BarbagalloIgnazio Barbagallo
Ignazio Barbagallo
Fabio GalvanoFabio Galvano
Fabio Galvano
AFAlessandro Frigiola
Alessandro Frigiola
Francesco CappelloFrancesco Cappello
Francesco Cappello
GRGraziano Riccioni
Graziano Riccioni
Giovanni Li VoltiGiovanni Li Volti
Giovanni Li Volti
Many physiological effects of natural antioxidants, their extracts or their major active components, have been reported in recent decades. Most of these compounds are characterized by a phenolic structure, similar to that of α-tocopherol, and present antioxidant properties that have been demonstrated both in vitro and in vivo. Polyphenols may increase the capacity of endogenous antioxidant defenses and modulate the cellular redox state. Such effects may have wide-ranging consequences for cellular growth and differentiation. The majority of in vitro and in vivo studies conducted so far have attributed the protective effect of bioactive polyphenols to their chemical reactivity toward free radicals and their capacity to prevent the oxidation of important intracellular components. One possible protective molecular mechanism of polyphenols is nuclear factor erythroid 2-related factor (Nrf2) activation, which in turn regulates a number of detoxification enzymes. Among the latter, the heme oxygenase-1 (HO-1) pathway is likely to contribute to the established and powerful antioxidant/anti-inflammatory properties of polyphenols. In this context, it is interesting to note that induction of HO-1 expression by means of natural compounds contributes to prevention of cardiovascular diseases in various experimental models. The focus of this review is on the role of natural HO-1 inducers as a potential therapeutic strategy to protect the cardiovascular system against various stressors in several pathological conditions.

1 March 2012 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
RMRaffaele Marfella
Raffaele Marfella
FSFerdinando Carlo Sasso
Ferdinando Carlo Sasso
FCFederico Cacciapuoti
Federico Cacciapuoti
MPMichele Portoghese
Michele Portoghese
MRMaria Rosaria Rizzo
Maria Rosaria Rizzo
Giuseppe PaolissoGiuseppe Paolisso
Giuseppe Paolisso
Aims: We analyzed the effects of tight glycemic control on regenerative potential of myocardium during acute myocardial infarction. Patients and Methods: Seventy-five patients with their first acute myocardial infarction undergoing coronary bypass surgery were studied: 25 patients with glycemia below 140 mg/dl served as the control group; hyperglycemic patients (glucose >140 mg/dl) were randomized to intensive glycemic control (IGC; n = 20; glucose goal, 80–140 mg/dl), conventional glycemic control (CGC; n = 20; glucose goal, 180–200 mg/dl), or glucose-insulin-potassium (GIK; n = 10; glucose goal, 180–200 mg/dl) for almost 3 d before surgery, using insulin infusion followed by sc insulin treatment. During surgery, myocyte precursor cells (MPC) (c-kit/MEFC2/GATA4-positive cells), oxidation of MPC DNA (c-kit/8-hydroxydeoxyguanosine-positive cells), senescent MPC (c-kit/p16INK4a-positive cells), and cycling cardiomyocytes (Ki-67-positive cells) were analyzed in biopsy specimens taken from the peri-infarcted area. Results and Discussion: Before surgery, plasma glucose reduction was greater in the IGC group than in the CGC and GIK groups (P < 0.001 for both). IGC patients had higher MPC (P < 0.01) and cycling myocytes (P < 0.01), as well as less oxidized (P < 0.01) and senescent MPC (P < 0.01) in peri-infarcted specimens compared with both CGC and GIK patients. Tight glycemic control, by reducing senescent MPC, may increase regenerative potential of the ischemic myocardium.